Search research articles
Contact Us
Filters
Showing results (211-220 of 222) with videos related to
Page
of 23
Sort By:
Catheterization and Cardiovascular Diagnosis
|
January 1, 1979
Profiles of radionuclide left ventricular ejection fraction changes induced by supine bicycle exercise in normals and patients with coronary heart disease
M Pfisterer, R A Slutsky, G Schuler, et al.
International Journal of Cardiology
|
September 26, 2013
Improved two-year outcomes after drug-eluting versus bare-metal stent implantation in women and men with large coronary arteries: importance of vessel size
K W Hansen, C Kaiser, A Hvelplund, et al.
Thrombosis and Haemostasis
|
January 1, 1996
Aprotinin in aortocoronary bypass surgery: increased risk of vein-graft occlusion and myocardial infarction? Supportive evidence from a retrospective study
J van der Meer, H L Hillege, C A Ascoop, et al.
Journal of the American College of Cardiology
|
November 1, 1994
Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study
J van der Meer, A Brutel de la Rivière, W H van Gilst, et al.
Chemical Science
|
August 25, 2023
Parallel multi-droplet platform for reaction kinetics and optimization
Natalie S Eyke, Timo N Schneider, Brooke Jin, et al.
European Heart Journal
|
November 10, 2000
Lack of progress in cardiogenic shock: lessons from the GUSTO trials
V Menon, J S Hochman, A Stebbins, et al.
Circulation
|
November 1, 1994
A comparison of internal mammary artery and saphenous vein grafts after coronary artery bypass surgery. No difference in 1-year occlusion rates and clinical outcome. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands
J van der Meer, H L Hillege, W H van Gilst, et al.
Journal of the American College of Cardiology
|
January 15, 2000
Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction
D Hasdai, R M Califf, T D Thompson, et al.
Journal of the American College of Cardiology
|
September 19, 1998
Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries
M Pfisterer, J L Cox, C B Granger, et al.
Circulation
|
June 20, 2001
Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy
L K Newby, E M Ohman, R H Christenson, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 222) with videos related to
Sort By:
Page
of 23
Catheterization and Cardiovascular Diagnosis
|
January 1, 1979
Profiles of radionuclide left ventricular ejection fraction changes induced by supine bicycle exercise in normals and patients with coronary heart disease
M Pfisterer, R A Slutsky, G Schuler, et al.
International Journal of Cardiology
|
September 26, 2013
Improved two-year outcomes after drug-eluting versus bare-metal stent implantation in women and men with large coronary arteries: importance of vessel size
K W Hansen, C Kaiser, A Hvelplund, et al.
Thrombosis and Haemostasis
|
January 1, 1996
Aprotinin in aortocoronary bypass surgery: increased risk of vein-graft occlusion and myocardial infarction? Supportive evidence from a retrospective study
J van der Meer, H L Hillege, C A Ascoop, et al.
Journal of the American College of Cardiology
|
November 1, 1994
Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study
J van der Meer, A Brutel de la Rivière, W H van Gilst, et al.
Chemical Science
|
August 25, 2023
Parallel multi-droplet platform for reaction kinetics and optimization
Natalie S Eyke, Timo N Schneider, Brooke Jin, et al.
European Heart Journal
|
November 10, 2000
Lack of progress in cardiogenic shock: lessons from the GUSTO trials
V Menon, J S Hochman, A Stebbins, et al.
Circulation
|
November 1, 1994
A comparison of internal mammary artery and saphenous vein grafts after coronary artery bypass surgery. No difference in 1-year occlusion rates and clinical outcome. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands
J van der Meer, H L Hillege, W H van Gilst, et al.
Journal of the American College of Cardiology
|
January 15, 2000
Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction
D Hasdai, R M Califf, T D Thompson, et al.
Journal of the American College of Cardiology
|
September 19, 1998
Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries
M Pfisterer, J L Cox, C B Granger, et al.
Circulation
|
June 20, 2001
Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy
L K Newby, E M Ohman, R H Christenson, et al.
Page
of 23